149 related articles for article (PubMed ID: 37459583)
1. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
3. Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE).
Wang Z; Liu Q; Wilson CL; Easton J; Mulder H; Chang TC; Rusch MC; Edmonson MN; Rice SV; Ehrhardt MJ; Howell RM; Kesserwan CA; Wu G; Nichols KE; Downing JR; Hudson MM; Zhang J; Yasui Y; Robison LL
Clin Cancer Res; 2018 Dec; 24(24):6230-6235. PubMed ID: 30366939
[TBL] [Abstract][Full Text] [Related]
4. Polygenic Risk Score Improves Risk Stratification and Prediction of Subsequent Thyroid Cancer after Childhood Cancer.
Song N; Liu Q; Wilson CL; Sapkota Y; Ehrhardt MJ; Gibson TM; Morton LM; Chanock SJ; Neglia JP; Arnold MA; Michael JR; Gout AM; Mulder HL; Easton J; Bhatia S; Armstrong GT; Zhang J; Delaney A; Hudson MM; Robison LL; Yasui Y; Wang Z
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2096-2104. PubMed ID: 34465587
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
Teepen JC; Kremer LC; van der Heiden-van der Loo M; Tissing WJ; van der Pal HJ; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Versluys B; van Dulmen-den Broeder E; Visser O; Maduro JH; van Leeuwen FE; Ronckers CM;
Cancer Causes Control; 2019 Sep; 30(9):909-922. PubMed ID: 31300947
[TBL] [Abstract][Full Text] [Related]
6. Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts.
Richard MA; Mostoufi-Moab S; Rathore N; Baedke J; Brown AL; Chanock SJ; Friedman DN; Gramatges MM; Howell RM; Kamdar KY; Leisenring WM; Meacham LR; Morton LM; Oeffinger K; Robison LL; Sapkota Y; Sklar CA; Armstrong GT; Bhatia S; Lupo PJ
JCO Precis Oncol; 2022 Dec; 6():e2200239. PubMed ID: 36480781
[TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.
Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL
J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438
[TBL] [Abstract][Full Text] [Related]
8. Trans-ancestral genetic study of diabetes mellitus risk in survivors of childhood cancer: a report from the St. Jude Lifetime Cohort and the Childhood Cancer Survivor Study.
Im C; Neupane A; Baedke JL; Delaney A; Dixon SB; Chow EJ; Mostoufi-Moab S; Richard MA; Gramatges MM; Lupo PJ; Sharafeldin N; Bhatia S; Armstrong GT; Hudson MM; Ness KK; Robison LL; Yasui Y; Wilson CL; Sapkota Y
medRxiv; 2023 Jun; ():. PubMed ID: 37333357
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors.
Gibson TM; Karyadi DM; Hartley SW; Arnold MA; Berrington de Gonzalez A; Conces MR; Howell RM; Kapoor V; Leisenring WM; Neglia JP; Sampson JN; Turcotte LM; Chanock SJ; Armstrong GT; Morton LM
Nat Med; 2024 Mar; 30(3):690-698. PubMed ID: 38454124
[TBL] [Abstract][Full Text] [Related]
11. Subsequent neoplasms in childhood cancer survivors.
Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study.
Friedman DN; Goodman PJ; Leisenring WM; Diller LR; Cohn SL; Howell RM; Smith SA; Tonorezos ES; Wolden SL; Neglia JP; Ness KK; Gibson TM; Nathan PC; Weil BR; Robison LL; Oeffinger KC; Armstrong GT; Sklar CA; Henderson TO
J Clin Oncol; 2023 Mar; 41(8):1565-1576. PubMed ID: 36525618
[TBL] [Abstract][Full Text] [Related]
13. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
14. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
15. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer.
Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort.
Im C; Lu Z; Mostoufi-Moab S; Delaney A; Yu L; Baedke JL; Han Y; Sapkota Y; Yasui Y; Chow EJ; Howell RM; Bhatia S; Hudson MM; Ness KK; Armstrong GT; Nathan PC; Yuan Y
Lancet Oncol; 2023 Dec; 24(12):1434-1442. PubMed ID: 37972608
[TBL] [Abstract][Full Text] [Related]
17. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC
Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813
[TBL] [Abstract][Full Text] [Related]
18. Subsequent Breast Cancer in Female Childhood Cancer Survivors in the St Jude Lifetime Cohort Study (SJLIFE).
Ehrhardt MJ; Howell CR; Hale K; Baassiri MJ; Rodriguez C; Wilson CL; Joshi SS; Lemond TC; Shope S; Howell RM; Wang Z; Srivastava D; Mulrooney DA; Zhang J; Robison LL; Ness KK; Hudson MM
J Clin Oncol; 2019 Jul; 37(19):1647-1656. PubMed ID: 31075046
[TBL] [Abstract][Full Text] [Related]
19. Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987-2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France.
Casagranda L; Oriol M; Freycon F; Frappaz D; Bertrand Y; Bergeron C; Plantaz D; Stephan JL; Freycon C; Gomez F; Berger C; Trombert-Paviot B
Pediatr Hematol Oncol; 2016 Sep; 33(6):371-382. PubMed ID: 27687523
[TBL] [Abstract][Full Text] [Related]
20. Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors.
Im C; Yuan Y; Austin ED; Stokes DC; Krasin MJ; Davidoff AM; Sapkota Y; Wang Z; Ness KK; Wilson CL; Armstrong GT; Hudson MM; Robison LL; Mulrooney DA; Yasui Y
Cancer Res; 2022 Aug; 82(16):2940-2950. PubMed ID: 35713625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
